Shuttle Pharmaceuticals Holdings, Inc. - 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the Annual Meeting of Shareholders held by Shuttle Pharmaceuticals Holdings, Inc. on December 18, 2023. The Company is a Delaware corporation with its principal executive offices in Gaithersburg, MD, and its common stock trades on The Nasdaq Stock Market under the symbol "SHPH".
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
Shareholders voted on three primary matters at the Annual Meeting:
- Election of Directors: All six nominees were elected to the Board of Directors for a one-year term. Voting results were as follows:
- Anatoly Dritschilo, MD: 7,823,591 For; 360,473 Withheld.
- Milton Brown, MD, PhD: 7,841,329 For; 342,735 Withheld.
- Chris Senanayake, PhD: 7,823,607 For; 360,457 Withheld.
- Steven Richards: 7,826,170 For; 357,894 Withheld.
- Joshua Schafer: 7,823,527 For; 360,537 Withheld.
- Bette Jacobs, PhD: 7,823,624 For; 360,440 Withheld.
- Ratification of Independent Auditors: Shareholders ratified the appointment of FORVIS LLP as the independent auditors for the fiscal year ending December 31, 2023.
- For: 10,791,925
- Against: 32,369
- Abstain: 185,622
- Executive Compensation: Shareholders approved the Company's executive compensation on an advisory basis.
- For: 7,807,163
- Against: 375,059
- Abstain: 1,842
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Key Facts for Investor Verification
- Confirm the composition of the newly elected Board of Directors and their terms.
- Verify the engagement of FORVIS LLP as the independent auditor for the 2023 fiscal year.
- Note the significant number of votes withheld on director elections (approximately 360,000 per nominee) compared to the "For" votes.
- Review the "Against" votes on executive compensation (375,059) to assess shareholder sentiment regarding pay practices.